一个单一中心的经验是,罕见癌症患者被转诊参加早期临床试验
Angelos Angelakas1, Natalie Cook2,1, Donna M Graham2,1
1Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
BMC cancer
|March 28, 2025
概括
患有罕见癌症的患者可能从早期临床试验 (EPCT) 中受益,显示出更好的生存结果. 精准医学是选择针对性治疗在这个多样化的患者群体的关键.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 基因组学就是基因组学.
背景情况:
- 罕见的癌症,定义为<6/100,000/年,占所有癌症的25%.
- 与常见癌症相比,这些癌症的存活率较低.
- 早期临床试验 (EPCT) 为罕见癌症患者提供了潜在的治疗途径,越来越多地纳入精准医学.
研究的目的:
- 为了评估罕见癌症患者的结果,他们被转介到早期临床试验团队.
- 评估EPCT参与对生存的影响.
- 探索分子分析和精密医学在罕见癌症中的作用.
主要方法:
- 在5年的时间里 (2016-2020年) 对240名罕见癌症患者进行了回顾性分析.
- 收集的数据包括人口统计,病史,基因组变异和EPCT参与.
- 分析了生存结果,治疗反应和预后得分.
主要成果:
- 消化道,女性生殖道和头癌最常见.
- 分子分析在60.2%的分析患者中发现了可操作的基因变异.
- 参与EPCT的患者的平均寿命为16个月,而非参与者的平均寿命为7个月;预后不佳的得分与生存率差异相关.
结论:
- 参与EPCT可能为罕见癌症患者提供生存优势.
- 电子血清疗法有助于开发用于罕见恶性瘤的新型治疗方法.
- 精准医学对于指导异质罕见癌症群体的向治疗选择至关重要.
更多相关视频
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
04:11A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
Published on: June 9, 2026
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
